Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 54 citing Araki: APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects.... (0.10 sec) 

Mouse models of diabetic nephropathy

- asnjournals.org
MD Breyer, E Bottinger, FC Brosius III, TM … - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol
Mice provide an experimental model of unparalleled flexibility for studying
mammalian diseases. Inbred strains of mice exhibit substantial differences in
their susceptibility to the renal complications of diabetes. Much remains ...
Cited by 104 - Related articles - All 6 versions

Lipoproteins and diabetic microvascular complications


AJ Jenkins, KG Rowley, TJ Lyons, JD Best, MA … - Current pharmaceutical design, 2004 - ingentaconnect.com
AJ Jenkins 1,2,3, * , KG Rowley 1 , TJ Lyons 2,3 , JD Best 1 , MA Hill 2,4 and
RL Klein 3 ... 1 University of Melbourne, Department of Medicine, St Vincent's
Hospital, Melbourne, Australia; ... Endocrinology, Metabolism and ...
Cited by 38 - Related articles - BL Direct - All 4 versions

Factors associated with frequent remission of microalbuminuria in patients with type 2 …

- diabetesjournals.org
S Araki, M Haneda, T Sugimoto, M Isono, K … - Diabetes, 2005 - Am Diabetes Assoc
To estimate the frequency of remission/regression of microalbuminuria and to
identify factors affecting such outcomes in Japanese patients with type 2
diabetes, we observed 216 patients with type 2 diabetes and ...
Cited by 33 - Related articles - BL Direct - All 5 versions

Apolipoprotein E and progression of chronic kidney disease


CC Hsu, WH Kao, J Coresh, JS Pankow, J … - Jama, 2005 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Apolipoprotein E ...
Cited by 32 - Related articles - All 3 versions

Molecular genetic approaches for studying the etiology of diabetic nephropathy


DPK Ng, AS Krolewski - Current Molecular Medicine, 2005 - ingentaconnect.com
1 Department of Community, Occupational and Family Medicine, and Centre for
Molecular Epidemiology, National University of Singapore 2 Joslin Diabetes
Center, and Department of Medicine, Harvard Medical School, Boston, MA, USA ...
Cited by 22 - Related articles - BL Direct - All 3 versions

Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate …

- asnjournals.org
E Boes, D Fliser, E Ritz, P Konig, K Lhotta, … - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol
It has not been established firmly whether dyslipidemia contributes
independently to the progression of kidney disease. Lipid and lipoprotein
parameters, including levels of total, HDL, and LDL cholesterol; ...
Cited by 21 - Related articles - BL Direct - All 7 versions

Association of APOE (Hha1) and ACE (I/D) gene polymorphisms with type 2 diabetes mellitus …


PP Singh, I Naz, A Gilmour, M Singh, S … - Diabetes research and clinical practice, 2006 - Elsevier
Familial and epidemiological studies have shown that genetic factors play a role
in the development and progression of type 2 diabetes mellitus (T2DM). Asian
Indians have shown an increasing prevalence of T2DM. Apolipoprotein E ...
Cited by 16 - Related articles - All 13 versions

Association of CETP TaqI and APOE polymorphisms with type II diabetes mellitus in North …


M Dixit, S Bhattacharya, B Mittal - BMC Endocrine Disorders, 2005 - biomedcentral.com
Although CETP TaqI B polymorphism was not associated with the T2DM, yet B1B2
genotype was significantly (p = 0.028) associated with high risk of hypertension
in diabetic patients (OR = 3.068, 95% CI 1.183–7.958). In North Indians ...
Cited by 15 - Related articles - Cached - All 7 versions

Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3-455T> C …


MCY Ng, L Baum, WY So, VKL Lam, Y Wang, E … - Clinical genetics, 2006 - interscience.wiley.com
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. In DN
patients, triglyceride (TG) level is elevated and lipoprotein lipase (LPL)
activity, which hydrolyzes TG, is decreased. The LPL S447X and ...
Cited by 12 - Related articles - BL Direct - All 6 versions

Pharmacogenomics, nutrigenomics and future therapeutics in Alzheimer's disease


R Cacabelos, M Takeda - Drugs Future, 2006 - journals.prous.com
Abstract Alzheimer's disease (AD) is a major health problem in developed
countries, representing an important socioeconomic burden for the community.
Approximately, 10% of the direct costs of AD are attrib- uted to ...
Cited by 11 - Related articles - All 2 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google